Follow every step in order
Jessica Duncan testified before the FDA to advocate for peptide access
Collectively, these findings highlight cotadutides dual benefits for glycemic control and liver health, supporting its further development for T2D, obesity, and NASH treatment [85]
Attend any follow-up appointments so your clinician can review progress and plan the next session
Brand-Name Pricing (2026) Mounjaro (Diabetes Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: On shortage list periodically Zepbound (Weight Loss Indication): List price: $1,069/month ($12,828/year) Without insurance: Pay full price With insurance: $25-$300/month copay (if covered) Availability: Limited, shortage issues Manufacturer Savings Cards: Eli Lilly offers savings card Reduces cost to $25-$50/month Requirements: Commercial insurance (not Medicare/Medicaid) Exclusions: Cash-pay patients ineligible Income limits: May apply For uninsured or underinsured patients, brand-name is unaffordable at $1,069/month